Form 4: Pactiv Evergreen CFO Jonathan Baksht Acquires Shares Through Accelerated Vesting and Merger Agreement

Sentiment:

SEC Form 4 Filing


Pactiv Evergreen's Chief Financial Officer, Jonathan Baksht, acquired a significant number of shares due to accelerated vesting of restricted stock units and performance share units, along with a merger agreement.

Better than expectedThe performance share units were settled at 200% of target, indicating better than expected performance.

Summary

  • Jonathan Baksht, the Chief Financial Officer of Pactiv Evergreen Inc., acquired shares of common stock on December 16, 2024.
  • The acquisitions resulted from the accelerated vesting of 89,004 restricted stock units and 93,843 performance share units.
  • These units were originally scheduled to vest in 2025 but were accelerated due to a merger agreement.
  • The performance share units were settled at 200% of the target due to the achievement of performance criteria.
  • A total of 6,692 shares were acquired from dividend equivalent rights related to the restricted stock units.
  • An additional 207,839 shares were acquired from the vesting of the performance share units and associated dividend equivalent rights.
  • 134,468 shares were withheld to cover tax liabilities related to the vesting of the units.
  • The merger agreement was dated December 9, 2024, between Pactiv Evergreen, Novolex Holdings, LLC, and Alpha Lion Sub, Inc.

Sentiment

Score: 7

Explanation: The document indicates positive performance with the 200% settlement of performance share units, and the CFO's share acquisition suggests confidence. However, the merger introduces some uncertainty.

Positives

  • The accelerated vesting of performance share units at 200% of target indicates strong performance achievement.
  • The acquisition of shares by the CFO could be seen as a positive sign of confidence in the company's future.

Negatives

  • A significant number of shares were withheld to cover tax liabilities, which could be seen as a reduction in the overall benefit to the CFO.

Risks

  • The merger agreement could introduce uncertainties and risks for the company.
  • The accelerated vesting of shares could potentially dilute existing shareholders.

Industry Context

This filing is related to a merger agreement, which is a significant event in the packaging industry. Mergers and acquisitions can lead to consolidation and changes in market dynamics.

Comparison to Industry Standards

  • Share-based compensation is a common practice in publicly traded companies, and the vesting of restricted stock units and performance share units is a standard method of incentivizing executives.
  • The 200% settlement of performance share units suggests that Pactiv Evergreen's performance exceeded expectations, which is a positive sign compared to industry peers.
  • Companies like Berry Global and Amcor also use similar compensation structures, but the specific terms and performance targets vary.

Stakeholder Impact

  • Shareholders may view the accelerated vesting and performance-based settlement positively, as it indicates strong company performance.
  • Employees may be impacted by the merger agreement, but the details are not provided in this document.

Key Dates

DateDescription
12/09/2024Date of the Agreement and Plan of Merger between Pactiv Evergreen, Novolex Holdings, LLC, and Alpha Lion Sub, Inc.
12/16/2024Date of the share acquisitions by Jonathan Baksht.
12/18/2024Date of the signature of the report by Tyler T. Rosenbaum, Assistant Secretary, by Power of Attorney.

Keywords

Pactiv Evergreen, Jonathan Baksht, Merger Agreement, Share Acquisition, Restricted Stock Units, Performance Share Units, Vesting, Dividend Equivalent Rights, Tax Withholding

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.